Korean name: 유니벡스대나무잎추출물. This page reports what South Korea's
Ministry of Food and Drug Safety has approved for this ingredient.
MFDS recognition no.
2005-1
Approval route
Notified (고시형) — listed in MFDS public standards
Daily intake (as approved)
0.345–2.07 mg/일
Approval holder
(주)유니젠
Approved functional claim (Korean original)
The text below is the approved wording as published by MFDS. It is reproduced without
modification. Any translation is provided for comprehension only and carries no regulatory
standing.
◆ "유니벡스 대나무잎추출물은 혈중 콜레스테롤 및 지질 조절, 항산화 효과에 도움을 줄 수 있으나 인체시험을 통한 확인이 필요합니다."
(동물시험에서 혈중 콜레스테롤 및 지질 조절, 항산화 효과에 도움을 줄 수 있음이 확인되었으나 인체시험 자료는 제출되지 않았음. 따라서 반드시 ‘--- 인체시험을 통한 확인이 필요합니다’의 형식으로 표시하여야 함.)
Precautions (Korean original)
◆ 임신 중이거나 수유 중인 분 또는 콜레스테롤 저하 약물을 복용 중인 분은 의사의 상담 하에 섭취하는 것이 좋습니다.
What this means for sourcing
An ingredient approved in Korea is not automatically permitted elsewhere. Importers should
verify status with their own authority. Conversely, Korean approval demonstrates that a dossier
on safety and function was reviewed under a national regulatory system, which many buyers treat
as a meaningful signal.
Regulatory approvals described on this page were issued by the Ministry of Food and Drug Safety (MFDS) of the Republic of Korea and are valid in South Korea only. They are not health claims in your jurisdiction and have not been evaluated by the FDA, EFSA, or any other authority. This page reports regulatory facts; it does not recommend or endorse any product.